EU Commission earmarks EUR 725m to secure critical production capacity
As a part of EU's new health authority, the Commission has set aside millions of euros to reserve the capacities of European manufacturers in times of need. The investment will create an "ever-warm" network of medical countermeasures.
BY PETER THOMSEN eu correspondent for Watch medier, translated by daniel pedersen
When the EU is arming itself against future health crises in the coming years, it will be backed with millions of euros to ensure fast access to a critical production capacity in Europe.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EU pharma strategy could allow for shorter drug patents
For subscribers
